Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Balance Sheet: Assets 
Quarterly Data

Abbott Laboratories, common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 10.16 9.57 8.67 9.42 9.31 10.68 12.41 13.28 13.18 12.04 10.37 13.03 12.61 11.82 11.07 9.43 6.49 6.93 5.06 5.69 5.97 4.58 4.47
Short-term investments 0.31 0.32 0.51 0.52 0.47 0.44 0.50 0.39 0.43 0.48 0.65 0.60 0.53 0.39 0.44 0.43 0.36 0.40 0.44 0.41 0.36 0.35 0.35
Trade receivables, less allowances 9.48 9.39 9.11 8.97 9.02 8.41 8.16 8.35 8.80 9.70 9.70 8.63 8.68 8.34 8.38 8.84 8.18 7.47 7.92 7.99 7.95 8.11 7.91
Finished products 5.61 5.56 5.61 5.39 5.34 5.46 5.34 5.11 4.68 4.81 4.69 4.10 4.13 4.26 4.42 4.18 4.60 4.71 4.30 4.10 4.15 4.07 3.91
Work in process 1.18 1.21 1.22 1.10 1.23 1.15 1.09 0.91 1.00 0.96 0.94 0.92 0.96 1.09 1.06 0.98 1.04 0.98 0.92 0.82 0.85 0.85 0.79
Materials 2.37 2.57 2.60 2.48 2.66 2.76 2.61 2.27 2.20 2.18 2.06 1.84 2.04 2.08 1.92 1.75 1.82 1.87 1.62 1.43 1.40 1.44 1.34
Inventories 9.16% 9.33% 9.42% 8.97% 9.22% 9.37% 9.04% 8.29% 7.88% 7.95% 7.69% 6.86% 7.13% 7.42% 7.40% 6.91% 7.46% 7.56% 6.84% 6.36% 6.41% 6.36% 6.04%
Prepaid expenses and other receivables 2.89 3.06 3.16 3.08 3.42 3.15 2.92 3.58 3.84 3.46 3.24 3.12 2.89 2.91 2.70 2.57 2.69 2.68 2.95 2.63 2.83 2.80 2.54
Current assets 32.01% 31.66% 30.88% 30.96% 31.44% 32.04% 33.03% 33.89% 34.13% 33.63% 31.66% 32.23% 31.83% 30.88% 29.97% 28.18% 25.19% 25.04% 23.21% 23.08% 23.52% 22.21% 21.31%
Investments 1.23 1.20 1.13 1.09 1.09 1.09 1.05 1.03 1.05 0.99 1.03 1.09 1.10 1.10 1.14 1.13 1.16 1.13 1.18 1.30 1.28 1.24 1.28
Property and equipment, at cost 30.74 30.21 30.43 29.96 29.28 28.53 27.92 27.15 26.52 26.22 26.38 25.75 25.99 26.03 25.69 25.90 26.03 25.26 25.02 24.75 23.84 23.87 23.52
Accumulated depreciation and amortization -16.46 -16.20 -16.49 -16.09 -16.03 -15.65 -15.34 -14.84 -14.58 -14.34 -14.34 -13.84 -14.03 -14.00 -13.55 -13.46 -13.55 -13.13 -13.18 -12.91 -12.43 -12.43 -12.25
Net property and equipment 14.28% 14.01% 13.95% 13.87% 13.25% 12.88% 12.58% 12.31% 11.94% 11.88% 12.04% 11.91% 11.97% 12.03% 12.13% 12.45% 12.48% 12.13% 11.84% 11.84% 11.42% 11.44% 11.28%
Intangible assets, net of amortization 9.89 10.72 11.45 12.04 12.88 13.41 13.56 14.04 14.90 15.62 16.52 16.94 18.04 18.67 19.48 20.38 22.03 22.95 24.36 25.08 25.48 26.44 27.32
Goodwill 31.82 31.92 32.27 32.34 32.29 31.71 31.07 30.63 30.61 30.65 31.32 30.89 31.57 32.05 32.13 32.73 33.80 33.56 34.33 34.17 33.62 34.09 34.33
Deferred income taxes and other assets 10.77 10.48 10.33 9.69 9.05 8.87 8.71 8.10 7.37 7.22 7.44 6.93 5.49 5.26 5.14 5.14 5.34 5.19 5.08 4.54 4.68 4.58 4.48
Long-term assets 67.99% 68.34% 69.12% 69.04% 68.56% 67.96% 66.97% 66.11% 65.87% 66.37% 68.34% 67.77% 68.17% 69.12% 70.03% 71.82% 74.81% 74.96% 76.79% 76.92% 76.48% 77.79% 78.69%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Abbott Laboratories current assets as a percentage of total assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Net property and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Abbott Laboratories net property and equipment as a percentage of total assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Abbott Laboratories long-term assets as a percentage of total assets decreased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.